Aptevo Therapeutics Inc

AED18.71
AED
Last updated on --.
24h volume118.47K
24h highest20.0735 AED
24h lowest18.3655 AED
24h Price movement+1.09%

APVO recent prices

24 Hours
+1.09%+AED0.20202
30 days
-2.60%-AED0.51056
60 days
+22.90%+AED3.566
90 days
-18.58%-AED4.368

Key data

Previous close18.5124 AED
Market cap22.47M AED
Volume118.47K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-82.0203 AED
Net income (FY)-96.44M AED
Revenue (FY)--
Last report dateMay 13, 2026

About Aptevo Therapeutics Inc

PHARMACEUTICAL PREPARATIONS
HeadquartersSEATTLE
Employees (FY)33.00
Net income per employee (FY)-2.92M AED
Listed onNasdaq
Official website

APVO conversion tables

APVOAPVO
AEDAED
0.5 APVO9.357 AED
1 APVO18.71 AED
5 APVO93.57 AED
10 APVO187.14 AED
AEDAED
APVOAPVO
0.5 AED0.026717 APVO
1 AED0.053435 APVO
5 AED0.26717 APVO
10 AED0.53435 APVO

FAQ

APVO is trading at AED18.71, +1.09% over the last 24 hours. Track live moves on the price chart at the top of this page.
The APVO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. APVO is currently trading at AED18.71, +1.09% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on APVO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. APVO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from APVO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against APVO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Aptevo Therapeutics Inc's market cap is currently 22.47M AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume118.47K
24h highest20.0735 AED
24h lowest18.3655 AED
24h Price movement+1.09%
APVOAPVO
AEDAED
Start trade with APVO Perpetual